Abstract
Colorectal cancer (CRC) is one of the most deadly groups of diseases. Apart from genetic mutations, other aspects such as environmental factors, unhealthy lifestyle and poor diet cause distress in gastrointestinal environment by changing physio-biochemical properties of luminal content which provides favourable environment for carcinogenesis. Administration of probiotics is helpful in prevention of carcinogenesis along with maintenance of microbial balance. They modulate patient’s gut during systemic cancer therapy and suppress oncogenic properties of the tumour cells by manipulating enzymes involved in mucosal immune response, inflammatory pathways, cell differentiation and proliferations. This chapter highlights huge scientific importance of probiotics as bio-therapeutics in cure and early prevention from CRC, with recent findings on anticancer effects, in vitro cell line and in vivo animal studies, safety and regulatory issues, challenges, precautions and future directions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Awaisheh SS, Obeidat MM, Al-Tamimi HJ, Assaf AM, EL-Qudah JM, Al-khaza’leh JM et al (2016) In vitro cytotoxic activity of probiotic bacterial cell extracts against Caco-2 and HRT-18 colorectal cancer cells. Milchwissenschaft 69(7):33–37
Bassaganya-Riera J, Viladomiu M, Pedragosa M, De Simone C, Hontecillas R (2012) Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteria. PLoS One 7(4):e34676
Bisgaard ML, Fenger K, Bulow S, Niebuhr E, Mohr J (1994) Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat 3(2):121–125
Blana VA, Grounta A, Tassou CC, Nychas GJE, Panagou EZ (2014) Inoculated fermentation of green olives with potential probiotic Lactobacillus pentosus and Lactobacillus plantarum starter cultures isolated from industrially fermented olives. Food Microbiol 38:208–218
de Moreno de Leblanc A, Perdigon G (2004) Yogurt feeding inhibits promotion and progression of experimental colorectal cancer. Med Sci Monit 10(4):BR96–B104
Di Caro S, Tao H, Grillo A, Elia C, Gasbarrini G, Sepulveda AR et al (2005) Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa. Dig Liver Dis 37(5):320–329
Fearon ER (2011) Molecular genetics of colorectal cancer. Annu Rev Pathol 6:479–507
Galdeano CM, Perdigon G (2006) The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin Vaccine Immunol 13(2):219–226
Golkhalkhali B, Rajandram R, Paliany AS, Ho GF, Wan Ishak WZ, Johari CS et al (2018) Strain-specific probiotic (microbial cell preparation) and omega-3 fatty acid in modulating quality of life and inflammatory markers in colorectal cancer patients: a randomized controlled trial. Asia Pac J Clin Oncol 14(3):179–191
Górska A, Przystupski D, Niemczura MJ, Kulbacka J (2019) Probiotic bacteria: a promising tool in cancer prevention and therapy. Curr Microbiol 76(8):939–949
Grimoud J, Durand H, de Souza S, Monsan P, Ouarne F, Theodorou V et al (2010) In vitro screening of probiotics and synbiotics according to anti-inflammatory and anti-proliferative effects. Int J Food Microbiol 144(1):42–50
Gryfe R, Swallow C, Bapat B, Redston M, Gallinger S, Couture J (1997) Molecular biology of colorectal cancer. Curr Probl Cancer 21(5):233–300
Guantario B, Zinno P, Schifano E, Roselli M, Perozzi G, Palleschi C et al (2018) In vitro and in vivo selection of potentially probiotic lactobacilli from nocellara del belice table olives. Front Microbiol 9:595
Guslandi M, Mezzi G, Sorghi M, Testoni PA (2000) Saccharomyces boulardii in maintenance treatment of Crohn’s disease. Dig Dis Sci 45(7):1462–1464
Haggar FA, Boushey RP (2009) Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 22(4):191–197
Hatakka K, Holma R, El-Nezami H, Suomalainen T, Kuisma M, Saxelin M et al (2008) The influence of Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp. shermanii JS on potentially carcinogenic bacterial activity in human colon. Int J Food Microbiol 128(2):406–410
Hynes NE, MacDonald G (2009) ErbB receptors and signaling pathways in cancer. Curr Opin Cell Biol 21(2):177–184
Indian Council of Medical Research Task Force, Co-ordinating Unit ICMR, Co-ordinating Unit DBT (2011) ICMR-DBT guidelines for evaluation of probiotics in food. Indian J Med Res 134(1):22–25
Jan G, Belzacq A-S, Haouzi D, Rouault A, Metivier D, Kroemer G et al (2002) Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria. Cell Death Differ 9(2):179–188
Janout V, Kollarova H (2001) Epidemiology of colorectal cancer. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 145(1):5–10
Karczewski J, Troost FJ, Konings I, Dekker J, Kleerebezem M, Brummer R-JM et al (2010) Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol 298(6):G851–G859
Lan A, Lagadic-Gossmann D, Lemaire C, Brenner C, Jan G (2007) Acidic extracellular pH shifts colorectal cancer cell death from apoptosis to necrosis upon exposure to propionate and acetate, major end-products of the human probiotic propionibacteria. Apoptosis 12(3):573–591
Larsson SC, Wolk A (2006) Meat consumption and risk of colorectal cancer: a meta-analysis of prospective studies. Int J Cancer 119(11):2657–2664
Le Leu RK, Hu Y, Brown IL, Woodman RJ, Young GP (2010) Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats. Carcinogenesis 31(2):246–241
Liu Z, Qin H, Yang Z, Xia Y, Liu W, Yang J et al (2011) Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery - a double-blind study. Aliment Pharmacol Ther 33(1):50–63
Ma EL, Choi YJ, Choi J, Pothoulakis C, Rhee SH, Im E (2010) The anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition. Int J Cancer 127(4):780–790
Madsen KL (2012) Enhancement of epithelial barrier function by probiotics. J Epithel Biol Pharmacol 5:55–59
Markowiak P, Śliżewska K (2017) Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients 9(9):pii: E1021
Molska M, Reguła J (2019) Potential mechanisms of probiotics action in the prevention and treatment of colorectal cancer. Nutrients 11:2453
Moser AR, Luongo C, Gould KA, McNeley MK, Shoemaker AR, Dove WF (1995) ApcMin: a mouse model for intestinal and mammary tumorigenesis. Eur J Cancer 31A(7–8):1061–1064
Nami Y, Haghshenas B, Haghshenas M, Abdullah N, Khosroushahi AY (2015) The prophylactic effect of probiotic Enterococcus lactis IW5 against different human cancer cells. Front Microbiol 6:1317
Ohkawara S, Furuya H, Nagashima K, Asanuma N, Hino T (2005) Oral administration of butyrivibrio fibrisolvens, a butyrate-producing bacterium, decreases the formation of aberrant crypt foci in the colon and rectum of mice. J Nutr 135(12):2878–2883
Parvez S, Malik KA, Ah Kang S, Kim H-Y (2006) Probiotics and their fermented food products are beneficial for health. J Appl Microbiol 100(6):1171–1185
Redman MG, Ward EJ, Phillips RS (2014) The efficacy and safety of probiotics in people with cancer: a systematic review. Ann Oncol 25(10):1919–1929
Rex DK, Ahnen DJ, Baron JA, Batts KP, Burke CA, Burt RW et al (2012) Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 107(9):1315–1329. quiz 1314, 1330
Saarela M, Mogensen G, Fondén R, Mättö J, Mattila-Sandholm T (2000) Probiotic bacteria: safety, functional and technological properties. J Biotechnol 84(3):197–215
Sanders ME (2008) Probiotics: definition, sources, selection, and uses. Clin Infect Dis 46(Suppl 2):S58–S61. discussion S144–51
Santarelli RL, Pierre F, Corpet DE (2008) Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence. Nutr Cancer 60(2):131–144
Singh J, Rivenson A, Tomita M, Shimamura S, Ishibashi N, Reddy BS (1997) Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis 18(4):833–841
Talseth-Palmer BA (2017) The genetic basis of colonic adenomatous polyposis syndromes. Hered Cancer Clin Pract 15(1):5
Tamime AY, Marshall VM, Robinson RK (1995) Microbiological and technological aspects of milks fermented by bifidobacteria. J Dairy Res 62(1):151–187
Tiptiri-Kourpeti A, Spyridopoulou K, Santarmaki V, Aindelis G, Tompoulidou E, Lamprianidou EE et al (2016) Lactobacillus casei exerts anti-proliferative effects accompanied by apoptotic cell death and up-regulation of TRAIL in colon carcinoma cells. PLoS One 11(2):e0147960
Uccello M, Malaguarnera G, Basile F, Dagata V, Malaguarnera M, Bertino G et al (2012) Potential role of probiotics on colorectal cancer prevention. BMC Surg 12(Suppl 1):S35
Vinderola G, Perdigon G, Duarte J, Farnworth E, Matar C (2006) Effects of the oral administration of the exopolysaccharide produced by Lactobacillus kefiranofaciens on the gut mucosal immunity. Cytokine 36(5–6):254–260
Wan Y, Xin Y, Zhang C, Wu D, Ding D, Tang L et al (2014) Fermentation supernatants of Lactobacillus delbrueckii inhibit growth of human colon cancer cells and induce apoptosis through a caspase 3-dependent pathway. Oncol Lett 7(5):1738–1742
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Yasir, M., Khare, R., Singh, P., Singh, S., Shrivastava, R. (2021). Possibility of Probiotic in Colorectal Cancer: A Specific Countenance to Research. In: Deol, P.K. (eds) Probiotic Research in Therapeutics. Springer, Singapore. https://doi.org/10.1007/978-981-15-8214-1_6
Download citation
DOI: https://doi.org/10.1007/978-981-15-8214-1_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-8213-4
Online ISBN: 978-981-15-8214-1
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)